Literature DB >> 9125579

Characterization of the physiological requirements for the bactericidal effects of a monoclonal antibody to OspB of Borrelia burgdorferi by confocal microscopy.

R Escudero1, M L Halluska, P B Backenson, J L Coleman, J L Benach.   

Abstract

A confocal microscopy study was undertaken to characterize the bactericidal effects of the Fab fragments of CB2, an immunoglobulin G1kappa murine monoclonal antibody, to an epitope in the carboxy region of the outer surface protein B (OspB) of Borrelia burgdorferi. Simultaneous direct labeling of both fixed and live spirochetes with fluorochrome-labeled Fab-CB2 and 11G1, and an immunoglobulin Mkappa monoclonal antibody to OspA, showed that OspA and OspB seem to colocalize in dead spirochetes but do not appear to be physically associated when the organisms are alive. A polar bleb composed of a Fab-CB2-OspB complex, followed by incorporation of 11G1-OspA, precedes the formation of a spheroplast. The spheroplasts contain both OspA and OspB and are a terminal stage in the bactericidal process induced by Fab-CB2. Outer membrane destabilization by Fab-CB2, but not cell wall or cytoplasmic membrane alterations, was demonstrated experimentally by the sequential treatment of spirochetes with Fab-CB2 and monoclonal antibodies to flagellin and DnaK. The action of Fab-CB2 is epitope specific, as another monoclonal antibody to an epitope in the amino terminus of OspB was not bactericidal. The bactericidal effect of Fab-CB2 is not dependent on the induction of spirochetal proteases but is dependent on the presence of Ca2+ and Mg2+. Supplementation of Ca2(+)- and Mg2(+)-free medium with these cations restored the bactericidal effects of Fab-CB2. The mechanism by which a Fab fragment of an antibody destroys a bacterium directly may represent a novel form of antibody-organism interaction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9125579      PMCID: PMC175240          DOI: 10.1128/iai.65.5.1908-1915.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

1.  A murine IgM monoclonal antibody binds an antigenic determinant in outer surface protein A, an immunodominant basic protein of the Lyme disease spirochete.

Authors:  J L Benach; J L Coleman; M G Golightly
Journal:  J Immunol       Date:  1988-01-01       Impact factor: 5.422

2.  Conjugation of antibodies with fluorochromes: modifications to the standard methods.

Authors:  J W Goding
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

3.  Lyme disease spirochetes and ixodid tick spirochetes share a common surface antigenic determinant defined by a monoclonal antibody.

Authors:  A G Barbour; S L Tessier; W J Todd
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

4.  Electron microscopy of the spherical body of oral spirochetes in vitro. Further studies.

Authors:  T Umemoto; I Namikawa
Journal:  Microbiol Immunol       Date:  1980       Impact factor: 1.955

5.  Murein-lipoprotein of Escherichia coli: a protein involved in the stabilization of bacterial cell envelope.

Authors:  H Suzuki; Y Nishimura; S Yasuda; A Nishimura; M Yamada; Y Hirota
Journal:  Mol Gen Genet       Date:  1978-11-16

6.  Limited surface exposure of Borrelia burgdorferi outer surface lipoproteins.

Authors:  D L Cox; D R Akins; K W Bourell; P Lahdenne; M V Norgard; J D Radolf
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

7.  Structural analysis of the Leptospiraceae and Borrelia burgdorferi by high-voltage electron microscopy.

Authors:  S F Goldstein; K F Buttle; N W Charon
Journal:  J Bacteriol       Date:  1996-11       Impact factor: 3.490

8.  Passive immunization of hamsters against experimental infection with the Lyme disease spirochete.

Authors:  R C Johnson; C Kodner; M Russell
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

9.  Isolation of antigenic components from the Lyme disease spirochete: their role in early diagnosis.

Authors:  J L Coleman; J L Benach
Journal:  J Infect Dis       Date:  1987-04       Impact factor: 5.226

10.  Action of penicillin on Borrelia hermsii.

Authors:  A G Barbour; W J Todd; H G Stoenner
Journal:  Antimicrob Agents Chemother       Date:  1982-05       Impact factor: 5.191

View more
  21 in total

1.  Pathogen-specific antibodies: codependent no longer.

Authors:  Edward N Janoff; Daniel N Frank
Journal:  J Clin Invest       Date:  2010-03-24       Impact factor: 14.808

2.  Analysis of antibody response in humans to the type A OspC loop 5 domain and assessment of the potential utility of the loop 5 epitope in Lyme disease vaccine development.

Authors:  Eric L Buckles; Christopher G Earnhart; Richard T Marconi
Journal:  Clin Vaccine Immunol       Date:  2006-10

3.  Killing of Borrelia burgdorferi by antibody elicited by OspA vaccine is inefficient in the absence of complement.

Authors:  J M Nowling; M T Philipp
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

Review 4.  A systematic review of Borrelia burgdorferi morphologic variants does not support a role in chronic Lyme disease.

Authors:  Paul M Lantos; Paul G Auwaerter; Gary P Wormser
Journal:  Clin Infect Dis       Date:  2013-12-12       Impact factor: 9.079

5.  Interactions of OspA monoclonal antibody C3.78 with Borrelia burgdorferi within ticks.

Authors:  Clay L Gipson; Aravinda M de Silva
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

6.  Characterization of multiprotein complexes of the Borrelia burgdorferi outer membrane vesicles.

Authors:  Xiuli Yang; Kamoltip Promnares; Jinhong Qin; Ming He; Deborah Y Shroder; Toru Kariu; Yan Wang; Utpal Pal
Journal:  J Proteome Res       Date:  2011-09-13       Impact factor: 4.466

Review 7.  Outer membrane proteins of pathogenic spirochetes.

Authors:  Paul A Cullen; David A Haake; Ben Adler
Journal:  FEMS Microbiol Rev       Date:  2004-06       Impact factor: 16.408

8.  OspB antibody prevents Borrelia burgdorferi colonization of Ixodes scapularis.

Authors:  Erol Fikrig; Utpal Pal; Manchuan Chen; John F Anderson; Richard A Flavell
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

9.  Decorin-binding proteins A and B confer distinct mammalian cell type-specific attachment by Borrelia burgdorferi, the Lyme disease spirochete.

Authors:  Joshua R Fischer; Nikhat Parveen; Loranne Magoun; John M Leong
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-28       Impact factor: 11.205

10.  Effect of complement component C3 deficiency on experimental Lyme borreliosis in mice.

Authors:  Matthew B Lawrenz; R Mark Wooten; James F Zachary; Scott M Drouin; Janis J Weis; Rick A Wetsel; Steven J Norris
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.